|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustment to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Provision (Recovery) for credit losses | ||
| Depreciation and amortization | ||
| Changes in fair value of derivative liability | ||
| Other non-cash expenses relating to ELOC Facility | ||
| Stock based compensation | ||
| Impairment loss on property and equipment | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Inventory | ||
| Tax refund receivable | ||
| Other current assets | ||
| Right of use asset – net | ||
| Operating lease liabilities | ||
| Accounts payable and accrued expenses | ||
| Deferred revenue | ||
| Corporate taxes payable | ||
| Deferred income taxes payable | ||
| Deferred tax liabilities | ||
| Net cash provided by (used in) operating activities | ||
| Cash flows used in investing activity: | ||
| Purchase of property and equipment | ||
| Net cash used in investing activity | ||
| Cash flows from (used in) financing activities: | ||
| Related party receivable | ||
| Related party loans | ||
| Deferred offering costs | ||
| Partner distributions | ||
| Net change note payable | ||
| Proceeds from IPO and overallotment, net | ||
| Proceeds from offering of ELOC shares | ||
| Net cash provided by (used in) financing activities | ||
| Increase (decrease) in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Supplemental disclosures of cash flow information: | ||
| Cash paid for interest | ||
| Issuance of Note Payable for payment of prepaid expense | ||
| Recognition of right of use asset and corresponding liability | ||
| Initial recognition of derivative liability | ||
| Right of use assets acquired and corresponding operating lease liability | ||
| Right-of-use assets and corresponding lease liabilities due to lease modifications | ||
| Reduction in allowance for credit losses | ||
| Membership exchange for common stock | ||
| Fair value of Stock Warrants issued at IPO | ||
| Deferred offering costs charged to additional paid-in-capital | ||
| Par value of shares issued for restricted stock award units vesting | ||
| Commitment shares adjustment to APIC | ||
| Other non-cash ELOC expenses |
Loading...
